Vicky Hsu

Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK

Christian Wagner, Ping Zhao, Y. Pan et al. · CPT Pharmacometrics & Systems Pharmacology · 2015 · 267 citations · Full text

FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma

Elaine Chang, Chana Weinstock, Lijun Zhang et al. · Clinical Cancer Research · 2020 · 173 citations · Full text

Peripheral Neuropathy, Urology, Seattle Genetics +14

Predicting the Effect of Cytochrome P450 Inhibitors on Substrate Drugs: Analysis of Physiologically Based Pharmacokinetic Modeling Submissions to the US Food and Drug Administration

Christian Wagner, Yuzhuo Pan, Vicky Hsu et al. · Clinical Pharmacokinetics · 2014 · 143 citations

Cytochrome P450 Inhibitors, Physiologically Based Pharmacokinetics, Pharmacokinetic Modeling +13

FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation

Kelly J. Norsworthy, Lola Luo, Vicky Hsu et al. · Clinical Cancer Research · 2019 · 133 citations

Differentiation Syndrome, Mixed-phenotype Acute Leukemia, Pharmacotherapy +16

Advancing Predictions of Tissue and Intracellular Drug Concentrations Using <i>In Vitro</i>, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches

Yingying Guo, Xiaoyan Chu, Neil Parrott et al. · Clinical Pharmacology & Therapeutics · 2018 · 113 citations · Full text

Engineering, Biomedical Engineering, Pharmacokinetic Modeling Approaches +17